[Treatment of paroxysmal disorders of cardiac rhythm].
D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000404:Ajmaline / Q000627:therapeutic use; D000605:Amino Alcohols / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000628:therapy*; D001281:Atrial Fibrillation / Q000628:therapy; D001282:Atrial Flutter / Q000628:therapy; D001949:Bretylium Compounds / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011437:Propylamines / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000628:therapy; D014693:Ventricular Fibrillation / Q000628:therapy
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D011437:Propylamines; D011725:Pyridines; D000404:Ajmaline; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine
Tratamentul tulburărilor paroxistice de ritm cardiac.